Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Attana ABNGM:ATANA Equity-to-Asset is 0.64 as of Jun. 2026, which is 7% below its 10-year median of 0.69. The stock has 3 warning signs investors should review. Among 210 Medical Diagnostics & Research companies, Attana AB ranks better than 56.67% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Attana AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr16.14 Mil. Attana AB's Total Assets for the quarter that ended in Jun. 2026 was kr25.42 Mil.
Therefore, Attana AB's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.64.
The historical rank and industry rank for Attana AB's Equity-to-Asset or its related term are showing as below:
NGM:ATANA'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32 Med: 0.69 Max: 0.89
Current: 0.64
During the past 9 years, the highest Equity to Asset Ratio of Attana AB was 0.89. The lowest was 0.32. And the median was 0.69.
NGM:ATANA's Equity-to-Asset is ranked better than 56.67% of 210
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.595
vs NGM:ATANA: 0.64
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Attana AB Equity-to-Asset Related Terms
Attana AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Attana AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:ATANA vs TMO, DHR, NTRA: Equity-to-Asset Comparison
For the Diagnostics & Research subindustry, Attana AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Attana AB Equity-to-Asset vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Attana AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Attana AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Attana AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Attana AB (NGM:ATANA) has a Equity-to-Asset of 0.64 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Attana AB and its competitors. This is near median its historical median of 0.69. Over the past decade, Attana AB's Equity-to-Asset has ranged from 0.32 to 0.89. According to the industry distribution chart, Attana AB ranks #91 out of 210 companies in the Medical Diagnostics & Research industry, placing it in the top 43.3%.
Is Attana AB's Equity-to-Asset too high?
Attana AB's current Equity-to-Asset of 0.64 is near median its 10-year median of 0.69. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 0.89. The Medical Diagnostics & Research industry median Equity-to-Asset is 0.60. Attana AB's value of 0.64 is 7.6% above this industry median. Based on the distribution chart, Attana AB ranks #91 out of 210 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does Attana AB's Equity-to-Asset compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Attana AB ranks #91 out of 210 companies for Equity-to-Asset. This puts Attana AB in the upper half of its industry. The industry median Equity-to-Asset is 0.60. Attana AB's value of 0.64 is 7.6% above this benchmark. Historically, Attana AB's own Equity-to-Asset has ranged from 0.32 to 0.89 over the past decade. While the company's 10-year median is 0.69 vs. the industry median of 0.60, Attana AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Diagnostics & Research company?
The median Equity-to-Asset among Medical Diagnostics & Research companies is 0.60, based on 210 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Attana AB's current Equity-to-Asset of 0.64 is 7.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Attana AB and its competitors. For the Medical Diagnostics & Research industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Attana AB's current Equity-to-Asset is 0.64, which is near median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attana AB stock overvalued right now?
Attana AB (NGM:ATANA) has a current Equity-to-Asset of 0.64. The current Equity-to-Asset is 0.64, which is near median its 10-year median of 0.69 and 7.6% above the Medical Diagnostics & Research industry median of 0.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Attana AB (NGM:ATANA), the current Equity-to-Asset is 0.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:ATANA has been successfully added to your 
